Literature DB >> 11163052

Daily cost of ophthalmic solutions for treating glaucoma in Japan.

H Ikeda1, E Sato, T Kitaura, H Fukuchi, Y Kimura, K Kihira.   

Abstract

PURPOSE: We conducted a study of the daily cost of various ophthalmic solutions used in Japan for treating glaucoma: beta-adrenergic blockers (11 products), epinephrine (3), cholinergics (3), prostaglandins (2), and carbonic anhydrase inhibitors (2).
METHODS: The total number of drops in one bottle of each solution was counted drop by drop. The cost per drop was calculated by dividing the government-controlled standard prices by the total number of drops in one bottle. The daily cost of therapy was calculated by multiplying the cost per drop by the number of drops typically used per day.
RESULTS: The average cost of each preparation was calculated based on the prices and the daily usage. The daily cost of the beta-adrenergic blockers studied ranged widely, from $0.43 to $1.04.
CONCLUSIONS: These data may be useful in selecting ophthalmic products for glaucoma therapy in Japan.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11163052     DOI: 10.1016/s0021-5155(00)00299-9

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  3 in total

Review 1.  Prostaglandin analogues for the treatment of glaucoma and ocular hypertension: a systematic review of economic evidence.

Authors:  Michelle Orme; Annabel Boler
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

2.  Daily Costs and Cost Effectiveness of Glaucoma Fixed Combinations in China.

Authors:  Chenjia Xu; Ruru Guo; Dandan Huang; Jian Ji; Wei Liu
Journal:  J Ophthalmol       Date:  2020-07-30       Impact factor: 1.909

3.  Influence of container structures and content solutions on dispensing time of ophthalmic solutions.

Authors:  Keiji Yoshikawa; Hiroshi Yamada
Journal:  Clin Ophthalmol       Date:  2010-05-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.